La investigación en oncología pediátrica en países de bajos ingresos
conceptos éticos y desafíos
Palabras clave:
Revisión ética, Consentimiento informado, Países de bajos ingresos, Oncología pediátrica, Ëtica de la investigación, Estándar de cuidado, Beneficios de pruebaResumen
Los avances desiguales en la investigación y la atención han dado lugar a discrepancias en los resultados del cáncer infantil entre los países de ingresos altos y bajos (LIC). La investigación colaborativa puede ayudar a mejorar los resultados en los países de ingreso bajo al generar conocimiento para las comunidades científicas locales, aumentar la traducción del conocimiento y fomentar la evaluación de los protocolos de tratamiento en contextos específicos. Sin embargo, los riesgos de tal investigación han recibido poca atención. Este artículo investiga la relación entre la investigación en oncología pediátrica en los países de ingresos bajos y cuatro temas centrales en la literatura sobre ética: estándar de atención, beneficios del ensayo, revisión ética y consentimiento informado. Nuestros objetivos son resaltar la importancia de este campo y la necesidad de una mayor investigación. Pediatr Blood Cancer 2012; 58:492–497.
Descargas
Citas
Ellison LF, Pogany L, Mery LS. Childhood and adolescent cancer survival: A period analysis of data from the Canadian Cancer Registry. Eur J Cancer 2007; 43:1967–1975.
Ribeiro RC, Steliarova-Foucher E, Magrath I, et al. Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving My Child Matters support: A descriptive study. Lancet Oncol 2008; 9:721–729.
Kellie SJ, Howard SC. Global child health priorities: What role for paediatric oncologists? Eur J Cancer 2008; 44:2388–2396.
Antillon F, Baez FL, Barr R, et al. AMOR: A proposed cooperative effort to improve outcomes of childhood cancer in Central America. Pediatr Blood Cancer 2005; 45:107–110.
Harif M, Barsaoui S, Benchekroun S, et al. Treatment of B-cell lymphoma with LMB modified protocols in Africa—Report of the French-African Pediatric Oncology Group (GFAOP). Pediatr Blood Cancer 2008; 50:1138–1142.
Howard SC, Marinoni M, Castillo L, et al. Improving outcomes for children with cancer in low-income countries in Latin America: A report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)-Part I. Pediatr Blood Cancer 2007;48:364–369.
Mostert S, Sitaresmi MN, Gundy CM, et al. Influence of socioeconomic status on childhood acute lymphoblastic leukemia treatment in Indonesia. Pediatrics 2006; 118:e1600–e1606.
Farmer P, Frenk J, Knaul FM, et al. Expansion of cancer care and control in countries of low and middle income: A call to action. Lancet 2010; 376:1186–1193.
Howard SC, Pedrosa M, Lins M, et al. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. JAMA 2004; 291:2471– 2475.
Ribeiro R, Pui CH. Treatment of acute lymphoblastic leukemia in low- and middle-income countries: Challenges and opportunities. Leuk Lymphoma 2008; 49:373–376.
Sloan FA, Gelband H, editors. Cancer control opportunities in low- and middle-income countries. Washington: The National Academies Press; 2007.
The World Bank. Data Catalog: Country Classifications. . Accessed.
Angell M. The ethics of clinical research in the Third World. N Engl J Med 1997; 337:847–849.
Lurie P, Wolfe SM. Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries. N Engl J Med 1997; 337:853–856.
Macklin R. After Helsinki: Unresolved issues in international research. Kennedy Inst Ethics J 2001; 11:17–36.
Shapiro HT, Meslin EM. Ethical issues in the design and conduct of clinical trials in developing countries. N Engl J Med 2001; 345:139–142.
Wendler D, Emanuel EJ, Lie RK. The standard of care debate: Can research in developing countries be both ethical and responsive to those countries’ health needs? Am J Public Health 2004;94:923–928.
Wertheimer A. Exploitation. Princeton, NJ: Princeton University Press; 1999.
US NBAC. 2001. Ethical and Policy Issues in International Research: Clinical Trials in Developing Countries. In US National Bioethics Advisory Commission [Online] . Accessed.
Angell M. Investigators’ responsibilities for human subjects in developing countries. N Engl J Med 2000; 342:967–969.
Brennan TA. Proposed revisions to the declaration of Helsinki— Will they weaken the ethical principles underlying human research? N Engl J Med 1999; 341:527–531.
Rothman KJ, Michels KB. The continuing unethical use of placebo controls. N Engl J Med 1994; 331: 394–398.
World Medical Association (WMA). 2008 [1964]. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. WHA [Online]. . Accessed.
Council for International Organizations of Medical Sciences (CIOMS). 2002. International Ethical Guidelines for Biomedical Research Involving Human Subjects. In Geneva: CIOMS [Online] . Accessed.
Benatar SR, Singer PA. A new look at international research ethics. BMJ 2000; 321:824–826.
Levine RJ. The ‘‘best proven therapeutic method’’ standard in clinical trials in technologically developing countries. IRB 1998; 20:5–9.
Resnik DB. The ethics of HIV research in developing nations. Bioethics 1998; 12:286–306.
Takala T. What is wrong with global bioethics? On the limitations of the four principles approach. Camb Q Healthc Ethics 2001; 10:72–77.
UK Nuffield Council on Bioethics. The Ethics of Research Related to Healthcare in Developing Countries. London, UK: Nuffield Council on Bioethics; 2002.
Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA 2000; 283:2701–2711.
Arras JD. Fair benefits in international medical research. Hastings Cent Rep 2004; 34:3–4.
Glantz LH, Annas GJ, Grodin MA, et al. Research in developing countries: Taking ‘‘benefit’’ seriously. Hastings Cent Rep 1998; 28:38–42.
Zong Z. Should post-trial provision of beneficial experimental interventions be mandatory in developing countries? J Med Ethics 2008; 34:188–192.
Benatar SR. Reflections and recommendations on research ethics in developing countries. Soc Sci Med 2002; 54:1131–1141.
Mari JJ, Lozano JM, Duley L. Erasing the global divide in health research. BMJ 1997; 314:390–391.
Lavery JV. Putting international research ethics guidelines to work for the benefit of developing countries. Yale J Health Policy Law Ethics 2004; 4:319–336.
Moral standards for research in developing countries: From ‘‘reasonable availability’’ to ‘‘fair benefits’’. Hastings Cent Rep 2004; 34:17–27.
Caniza MA, Clara W, Maron G, et al. Establishment of ethical oversight of human research in El Salvador: Lessons learned. Lancet Oncol 2006; 7:1027–1033.
Moodley K, Myer L. Health Research Ethics Committees in South Africa 12 years into democracy. BMC Med Ethics 2007; 8:1–8.
Emanuel EJ, Steiner D. Institutional conflict of interest. N Engl J Med 1995; 332:262–267.
Weijer C, Emanuel EJ. Ethics. Protecting communities in biomedical research. Science 2000; 289:1142–1144.
Ford N, Mills EJ, Zachariah R, et al. Ethics of conducting research in conflict settings. Confl Health 2009; 3:7–28.
Schopper D, Upshur R, Matthys F, et al. Research ethics review in humanitarian contexts: The experience of the independent ethics review board of Medecins Sans Frontieres. PLoS Med 2009;6: e1000115.
UNESCO. 2005. Universal Declaration on Bioethics and Human Rights. In United Nations Educational, Scientific and Cultural Organization [Online] <http://portal.unesco.org/en/ ev.php-URL_ID¼31058& URL_DO¼DO_TOPIC&URL_ SECTION¼201.html>. Accessed.
Indian Council for Medical Research. Ethical Guidelines for Biomedical Research on Human Subjects. New Delhi: ICMR; 2006.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.
Los textos académicos y científicos que se publican en la Revista La Universidad están protegidos bajo la licencia CC BY NC SA 4.0, esta permite usar una obra para crear otra obra o contenido, modificando o no la obra original, siempre que se cite al autor, la obra resultante se comparta bajo el mismo tipo de licencia y no tenga fines comerciales (https://creativecommons.org/licenses/by-nc-sa/4.0/deed.es) . El autor es el único que pose los derechos de publicación y la Revista La Universidad posee los derechos de difusión.
